| Doxorubicin | Approved Investigational | SCN5A | 6331 |
downregulated | Doxorubicin results in decreased expression of SCN5A mRNA | 3p22.2 | |
| Doxorubicin | Approved Investigational | SCNN1G | 6340 |
downregulated | Doxorubicin results in decreased expression of SCNN1G mRNA | 16p12.2 | |
| Doxorubicin | Approved Investigational | SEC22B | 9554 |
downregulated | Doxorubicin results in decreased expression of SEC22B mRNA | 1p12 | |
| Doxorubicin | Approved Investigational | SERPINE1 | 5054 |
downregulated | Doxorubicin results in decreased expression of SERPINE1 mRNA | 7q22.1 | |
| Doxorubicin | Approved Investigational | SERPINE1 | 5054 |
upregulated | Doxorubicin results in increased expression of SERPINE1 mRNA | 7q22.1 | |
| Doxorubicin | Approved Investigational | SERPINH1 | 871 |
upregulated | Doxorubicin results in increased expression of SERPINH1 mRNA | 11q13.5 | |
| Doxorubicin | Approved Investigational | SFN | 2810 |
downregulated | Doxorubicin results in decreased expression of SFN mRNA | 1p36.11 | |
| Doxorubicin | Approved Investigational | SLC2A1 | 6513 |
downregulated | Doxorubicin results in decreased expression of SLC2A1 mRNA | 1p34.2 | |
| Doxorubicin | Approved Investigational | SLC2A1 | 6513 |
upregulated | Doxorubicin results in increased expression of SLC2A1 mRNA | 1p34.2 | |
| Doxorubicin | Approved Investigational | SLIT3 | 6586 |
upregulated | Doxorubicin results in increased expression of SLIT3 mRNA | 5q34-q35.1 | |
| Doxorubicin | Approved Investigational | SNORD115-32 | 100033806 |
downregulated | Doxorubicin results in decreased expression of SNORD115-32 mRNA | 15q11.2 | |
| Doxorubicin | Approved Investigational | SNORD116-13 | 100033425 |
upregulated | Doxorubicin results in increased expression of SNORD116-13 mRNA | 15q11.2 | |
| Doxorubicin | Approved Investigational | SNORD64 | 347686 |
upregulated | Doxorubicin results in increased expression of SNORD64 mRNA | 15q11.2 | |
| Doxorubicin | Approved Investigational | SOD1 | 6647 |
upregulated | Doxorubicin results in increased expression of SOD1 mRNA | 21q22.11 | |
| Doxorubicin | Approved Investigational | SOD2 | 6648 |
upregulated | Doxorubicin results in increased expression of SOD2 mRNA | 6q25.3 | |
| Doxorubicin | Approved Investigational | SOS1 | 6654 |
upregulated | Doxorubicin results in increased expression of SOS1 mRNA | 2p22.1 | |
| Doxorubicin | Approved Investigational | SPARC | 6678 |
upregulated | Doxorubicin results in increased expression of SPARC mRNA | 5q33.1 | |
| Doxorubicin | Approved Investigational | SQLE | 6713 |
downregulated | Doxorubicin results in decreased expression of SQLE mRNA | 8q24.13 | |
| Doxorubicin | Approved Investigational | SSH3 | 54961 |
upregulated | Doxorubicin results in increased expression of SSH3 mRNA | 11q13.2 | |
| Doxorubicin | Approved Investigational | STAT1 | 6772 |
upregulated | Doxorubicin results in increased expression of STAT1 mRNA | 2q32.2 | |
| Doxorubicin | Approved Investigational | STAT2 | 6773 |
upregulated | Doxorubicin results in increased expression of STAT2 mRNA | 12q13.2 | |
| Doxorubicin | Approved Investigational | STAT3 | 6774 |
upregulated | Doxorubicin results in increased expression of STAT3 mRNA | 17q21.2 | |
| Doxorubicin | Approved Investigational | TAGLN | 6876 |
upregulated | Doxorubicin results in increased expression of TAGLN mRNA | 11q23.2 | |
| Doxorubicin | Approved Investigational | TERT | 7015 |
downregulated | Doxorubicin results in decreased expression of TERT mRNA | 5p15.33 | |
| Doxorubicin | Approved Investigational | TERT | 7015 |
downregulated | Doxorubicin results in decreased expression of TERT mRNA alternative form | 5p15.33 | |